Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions

Neurobiology of Disease

Volumn 74, Issue , 2015, Pages 14-24

  Alvarez, Jorge Ivan ^a   Saint Laurent, Olivia ^a   Godschalk, Alisha ^a   Terouz, Simone ^a   Briels, Casper ^a   Larouche, Sandra ^a   Bourbonnière, Lyne ^a   Larochelle, Catherine ^a   Prat, Alexandre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

(P)reactive lesion; Adherens junctions; Astrocytes; Blood brain barrier; EAE; Lesion; Multiple sclerosis; Tight junctions

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GADOLINIUM; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CELL INFILTRATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; ENCEPHALOMYELITIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MALE; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; SPONTANEOUS RELAPSING REMITTING EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TH1 CELL; TH17 CELL; UPREGULATION; WHITE MATTER LESION; ANIMAL; BRAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GLIOSIS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; GLIOSIS; HUMANS; LONGITUDINAL STUDIES; MALE; MICE, TRANSGENIC; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; T-LYMPHOCYTES;

EID: 84911486499     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.09.016     Document Type: Article

References (50)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7(1):41-53.
2. Allen I.V., McQuaid S., Mirakhur M., Nevin G. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol. Sci. 2001, 22(2):141-144.
3. Alvarez J.I., Teale J.M. Multiple expression of matrix metalloproteinases in murine neurocysticercosis: implications for leukocyte migration through multiple central nervous system barriers. Brain Res. 2008, 1214:145-158.
4. Alvarez J.I., Krishnamurthy J., Teale J.M. Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity. Am. J. Pathol. 2009, 175(2):685-695.
5. Alvarez J.I., Dodelet-Devillers A., Kebir H., Ifergan I., Fabre P.J., Terouz S., Sabbagh M., Wosik K., Bourbonniere L., Bernard M., et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011, 334(6063):1727-1731.
6. Alvarez J.I., Cayrol R., Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta 2011, 1812(2):252-264.
7. Argaw A.T., Gurfein B.T., Zhang Y., Zameer A., John G.R. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(6):1977-1982.
8. Begley D.J., Brightman M.W. Structural and functional aspects of the blood-brain barrier. Prog. Drug Res. 2003, 61:39-78.
9. Bennett J.L., Stuve O. Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Clin. Neuropharmacol. 2009, 32(3):121-132.
10. Buhler L.A., Samara R., Guzman E., Wilson C.L., Krizanac-Bengez L., Janigro D., Ethell D.W. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis. BMC Neurosci. 2009, 10:17.
11. Cayrol R., Wosik K., Berard J.L., Dodelet-Devillers A., Ifergan I., Kebir H., Haqqani A.S., Kreymborg K., Krug S., Moumdjian R., et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008, 9(2):137-145.
12. Cristante E., McArthur S., Mauro C., Maggioli E., Romero I.A., Wylezinska-Arridge M., Couraud P.O., Lopez-Tremoleda J., Christian H.C., Weksler B.B., et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(3):832-841.
13. De Groot C.J., Bergers E., Kamphorst W., Ravid R., Polman C.H., Barkhof F., van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001, 124(Pt 8):1635-1645.
14. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121(Pt 13):2115-2122.
15. Du D., Xu F., Yu L., Zhang C., Lu X., Yuan H., Huang Q., Zhang F., Bao H., Jia L., et al. The tight junction protein, occludin, regulates the directional migration of epithelial cells. Dev. Cell 2010, 18(1):52-63.
16. Fabis M.J., Scott G.S., Kean R.B., Koprowski H., Hooper D.C. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(13):5656-5661.
17. Fazekas F., Ropele S., Enzinger C., Seifert T., Strasser-Fuchs S. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult. Scler. 2002, 8(6):479-484.
18. Ferreri D.M., Minnear F.L., Yin T., Kowalczyk A.P., Vincent P.A. N-cadherin levels in endothelial cells are regulated by monolayer maturity and p120 availability. Cell Commun. Adhes. 2008, 15(4):333-349.
19. Filippi M., Rocca M.A., Martino G., Horsfield M.A., Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol. 1998, 43(6):809-814.
20. Frischer J.M., Bramow S., Dal-Bianco A., Lucchinetti C.F., Rauschka H., Schmidbauer M., Laursen H., Sorensen P.S., Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132(Pt 5):1175-1189.
21. Gaitan M.I., Shea C.D., Evangelou I.E., Stone R.D., Fenton K.M., Bielekova B., Massacesi L., Reich D.S. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann. Neurol. 2011, 70(1):22-29.
22. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57(2):173-185.
23. Hikita A., Tanaka N., Yamane S., Ikeda Y., Furukawa H., Tohma S., Suzuki R., Tanaka S., Mitomi H., Fukui N. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. Biochem. Cell Biol. 2009, 87(4):581-593.
24. Ifergan I., Kebir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N., Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 2008, 131(Pt 3):785-799.
25. Ifergan I., Kebir H., Terouz S., Alvarez J.I., Lecuyer M.A., Gendron S., Bourbonniere L., Dunay I.R., Bouthillier A., Moumdjian R., et al. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Ann. Neurol. 2011, 70(5):751-763.
26. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13(10):1173-1175.
27. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201(2):319-327.
28. Kubota K., Furuse M., Sasaki H., Sonoda N., Fujita K., Nagafuchi A., Tsukita S. Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr. Biol. 1999, 9(18):1035-1038.
29. Larochelle C., Cayrol R., Kebir H., Alvarez J.I., Lecuyer M.A., Ifergan I., Viel E., Bourbonniere L., Beauseigle D., Terouz S., et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 2012, 135(Pt 10):2906-2924.
30. Maeda A., Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1996, 55(3):300-309.
31. Maggi P., Cummings Macri S.M., Gaitan M.I., Leibovitch E., Wholer J.E., Knight H.L., Ellis M., Wu T., Silva A.C., Massacesi L., et al. The formation of inflammatory demyelinated lesions in cerebral white matter. Ann. Neurol. 2014, 76(4):594-608.
32. Moreno B., Jukes J.P., Vergara-Irigaray N., Errea O., Villoslada P., Perry V.H., Newman T.A. Systemic inflammation induces axon injury during brain inflammation. Ann. Neurol. 2011, 70(6):932-942.
33. Navaratna D., McGuire P.G., Menicucci G., Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 2007, 56(9):2380-2387.
34. Padden M., Leech S., Craig B., Kirk J., Brankin B., McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol. 2007, 113(2):177-186.
35. Plumb J., McQuaid S., Mirakhur M., Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002, 12(2):154-169.
36. Pollinger B., Krishnamoorthy G., Berer K., Lassmann H., Bosl M.R., Dunn R., Domingues H.S., Holz A., Kurschus F.C., Wekerle H. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 2009, 206(6):1303-1316.
37. Probert L., Eugster H.P., Akassoglou K., Bauer J., Frei K., Lassmann H., Fontana A. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain 2000, 123(Pt 10):2005-2019.
38. Schulz B., Pruessmeyer J., Maretzky T., Ludwig A., Blobel C.P., Saftig P., Reiss K. ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 2008, 102(10):1192-1201.
39. Singh S., Metz I., Amor S., van der Valk P., Stadelmann C., Bruck W. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol. 2013, 125(4):595-608.
40. Takeshita Y., Ransohoff R.M. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol. Rev. 2012, 248(1):228-239.
41. Tartaglia M.C., Narayanan S., De Stefano N., Arnaoutelis R., Antel S.B., Francis S.J., Santos A.C., Lapierre Y., Arnold D.L. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J. Neurol. 2002, 249(10):1382-1390.
42. Toft-Hansen H., Nuttall R.K., Edwards D.R., Owens T. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 2004, 173(8):5209-5218.
43. van der Valk P., Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 2009, 22(3):207-213.
44. van Horssen J., Bo L., Dijkstra C.D., de Vries H.E. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol. Dis. 2006, 24(3):484-491.
45. van Horssen J., Singh S., van der Pol S., Kipp M., Lim J.L., Peferoen L., Gerritsen W., Kooi E.J., Witte M.E., Geurts J.J., et al. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J. Neuroinflammation 2012, 9:156.
46. van Waesberghe J.H., Kamphorst W., De Groot C.J., van Walderveen M.A., Castelijns J.A., Ravid R., Lycklama A., Nijeholt G.J., van der Valk P., Polman C.H., Thompson A.J., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 1999, 46(5):747-754.
47. Vos C.M., Geurts J.J., Montagne L., van Haastert E.S., Bo L., van der Valk P., Barkhof F., de Vries H.E. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol. Dis. 2005, 20(3):953-960.
48. Werring D.J., Brassat D., Droogan A.G., Clark C.A., Symms M.R., Barker G.J., MacManus D.G., Thompson A.J., Miller D.H. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000, 123(Pt 8):1667-1676.
49. Yang G., Parkhurst C.N., Hayes S., Gan W.B. Peripheral elevation of TNF-alpha leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(25):10306-10311.
50. Yong V.W., Zabad R.K., Agrawal S., Goncalves Dasilva A., Metz L.M. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J. Neurol. Sci. 2007, 259(1-2):79-84.